Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

ClinicalTrials.gov ID: NCT01284517

Public ClinicalTrials.gov record NCT01284517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 6-week Double-blind, Placebo-controlled, Flexible-dose, Parallel-group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression in Subjects Demonstrating Non-response to Treatment With Lithium or Divalproex Alone.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lurasidone HCI is a compound that is a candidate for the treatment of bipolar I depression. This clinical study is designed to test the hypothesis that Lurasidone in combination with either Lithium or Divalproex is effective among patients with bipolar I depression.

Study identification

NCT ID
NCT01284517
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
356 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
Aug 2012 (Actual)
Completion
Aug 2012 (Actual)
Last update posted
Nov 26, 2013

2010 – 2012

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Clinical Innovations, Inc. Costa Mesa California 92647 —
Clinical Innovations Inc. Riverside California 92506 —
Artemis Institute for Clinical Research San Diego California 92123 —
Sharp Mesa Vista Hospital San Diego California 92123 —
Clinical Innovations inc. Santa Ana California 92705 —
Collaborative Neuroscience Network Torrance California 90502 —
Colorado Clinical Trials Inc. Highlands Ranch Colorado 80130 —
Accurate Clinical Trials Kissimmee Florida 34741 —
Clinical Neuroscience Solutions Inc. Orlando Florida 32806 —
Northwest Behavioral Research Center Roswell Georgia 30076 —
Institute for Behavioral Medicine LLC Smyrna Georgia 30080 —
Precise Research Centers Flowood Mississippi 39232 —
Village Clinical Research Inc. New York New York 10003 —
Medical & Behavioral Health Research New York New York 10023 —
Zarzar Psychiatric Associates, PLLC Raleigh North Carolina 27607 —
Summit Research Network (Oregon) Inc. Portland Oregon 97210 —
Lehigh Valley Hospital Allentown Pennsylvania 18103 —
Clinical Neuroscience Solutions, Inc. Memphis Tennessee 38119 —
FutureSearch Clinical Trials, LP Dallas Texas 75231 —
Pillar Clinical Research Dallas Texas 75243 —
Red Oak Psychiatry Associates, PA Houston Texas 77090 —
Summit Research Network (Seattle) LLC Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01284517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 26, 2013 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01284517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →